CAS No. |
2245848-05-7 |
|---|---|
中文名称 |
穆里扎托克拉克斯 |
英文名称 |
Murizatoclax |
别名 |
AMG 397;Murizatoclax;Spiro[5,7-etheno-1H,11H-cyclobut[i][1,4]oxazepino[3,4-f][1,2,7]thiadiazacyclohexadecine-2(3H),1′(2′H)-naphthalen]-8(9H)-one, 6′-chloro-3′,4′,12,13,16,16a,17,18,18a,19-decahydro-16-methoxy-11,12-dimethyl-16-[[(9aR)-octahydro-2H-pyrido[1,2-a]pyrazin-2-yl]methyl]-, 10,10-dioxide, (1′S,11R,12S,14E,16R,16aR,18aR)-;Spiro[5,7-etheno-1H,11H-cyclobut[i][1,4]oxazepino[3,4-f][1,2,7]thiadiazacyclohexadecine-2(3H),1'(2'H)-naphthalen]-8(9H)-one, 6'-chloro-3',4',12,13,16,16a,17,18,18a,19-decahydro-16-methoxy-11,12-dimethyl-16-[[(9aR)-octahydro-2H-pyrido[1,2-a]pyrazin-2-yl]methyl]-, 10,10-dioxide, (1'S,11R,12S,14E,16R,1... |
标准英文名 |
(1S,11'R,12'S,16'R,16a'R,18a'R,E)-6-chloro-16'-methoxy-11',12'-dimethyl-16'-(((R)-octahydro-2H-pyrido[1,2-a]pyrazin-2-yl)methyl)-3,4,12',13',16',16a',17',18',18a',19'-decahydro-1'H,2H,3'H,11'H-spiro[naphthalene-1,2'-[5,7]ethenocyclobuta[i][1,4]oxazepino[3,4-f][1]thia[2,7]diazacyclohexadecin]-8'(9'H)-one 10',10'-dioxide |
分子式 |
C42H57ClN4O5S |
分子量 |
765.46 |
精确分子量 |
764.37 |
SMILES |
C[C@H]1C/C=C/[C@@](CN2CCN3CCCC[C@@H]3C2)(OC)[C@@H]4CC[C@H]4CN5C[C@]6(COC7=C5C=C(C(NS(=O)([C@@H]1C)=O)=O)C=C7)CCCC8=C6C=CC(Cl)=C8 |
标准SMILES |
CO[C@]1(CN2C[C@H]3CCCCN3CC2)C=CC[C@H](C)[C@@H](C)S(=O)(=O)NC(=O)C2=CC3=C(C=C2)OC[C@@]2(CN3C[C@@H]3CC[C@@H]13)CCCC1C=C(Cl)C=CC2=1 |
用途 |
Murizatoclax (AMG 397) is a potent, selective, and orally active inhibitor of myeloid cell leukemia 1 (MCL-1) with a Ki value of 15 pM; it competitively binds to the BH3-binding groove of MCL-1, displacing pro-apoptotic BCL-2 family members; it is used in cancer research. |
InChIKey |
BJTFTQIBRVBSBH-VCQPVEJUSA-N |
|
|
评论 |
|---|